Sapreme Technologies

Antonie van Leeuwenhoeklaan 9, A12-1

37211MA Bilthoven

NL

Sapreme Technologies

Foundation date

3 aug 2016

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Biotechnical research and development on medical products and pharmaceutical processes and of food.

Full description:

Sapreme's mission is to develop improved macromolecular therapeutics such as antibody targeted antisense oligonucleotides (ASOs) for the treatment of cancer and other indications. Sapreme’s innovative endosomal escape platform is designed to allow therapeutics to reach their target without becoming entrapped by the endosome. Endosomal entrapment poses a significant hurdle for the drug discovery and development industry, currently limiting the development of a broad range of potential macromolecular therapeutics to ‘undruggable’ intracellular targets. An effective solution to endosomal entrapment could be of immense value to the therapeutic landscape, as it enables the development of truly differentiated therapeutics to such novel targets.

Upcoming events

Latest news

  • argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis

    Thursday September 21st 2023

  • Galapagos appoints Simon Sturge to its Board of Directors

    Tuesday September 19th 2023

  • 13th Investment for HERAN Partners: Broken String Biosciences (UK)

    Tuesday September 19th 2023